L-arginine, a nitric oxide (NO) precursor, can exert both ameriolative and
deteriorative effects on gastric mucosal lesions. This study was designed t
o determine whether exogenous L-arginine modulates stress-induced gastric m
ucosal lesions through NO production by either constitutive NO synthase (cN
OS) or inducible NO synthase (iNOS) in gastric mucosal tissues. In rats sub
jected to water immersion restraint stress over a 6-hour period, the concen
tration of gastric mucosal nitrite/nitrate, breakdown products of NO, incre
ased with the development of gastric mucosal lesions and a decrease in cNOS
activity and a drastic increase in iNOS activity in the gastric mucosal ti
ssue, Preadministration of L-arginine (150 to 600 mg/kg intraperitoneally)
attenuated the lesion development with prevention of increases in gastric m
ucosal nitrite/nitrate concentration and iNOS activity. In contrast, postad
ministration of L-arginine (150 to 600 mg/kg intraperitoneally) enhanced th
e lesion development with further increase in gastric mucosal nitrite/nitra
te concentration. This deteriorative action of postadministration of L-argi
nine (300 mg/kg intraperitoneally) was prevented by pretreatment with amino
guanidine (100 mg/kg subcutaneously), a selective iNOS inhibitor, with inhi
bition of increases in gastric mucosal iNOS activity and nitrite/nitrate co
ncentration, These results indicate that preadministered L-arginine protect
s against water immersion restraint stress-induced gastric mucosal lesions,
possibly through restricted NO production by cNOS in gastric mucosal tissu
es, whereas postadministered L-arginine aggravates the stress-induced gastr
ic mucosal lesions, possibly through excessive NO production by iNOS increa
sing in gastric mucosal tissues.